RxGen Advancing therapeutic development
 
 
about us
Drug development, through innovative research
RxGen applies its extensive experience with primate models of human physiology and disease to accelerate preclinical drug development. We apply our expertise to many areas of therapeutic and diagnostic interest for which clinically relevant models are feasible with a focus on CNS, ophthalmic and metabolic disorders and ADMET studies.
News

RxGen Announces New Executive Promotions

RxGen Supported Gene Silencing Study Reported in Nature

RxGen Strives to Validate the African Green Monkey for Preclinical Research